ACET
ACET
NASDAQ · Biotechnology

Adicet Bio Inc

$6.35
-2.67 (-29.60%)
As of Sep 28, 10:27 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +129.0% upside
Low Target $12.76
Average Target $14.54
High Target $24.66
Current Price $6.35
Current
$6.35
Target
$14.54
$12.76 $14.54 avg $24.66
Scenario Analysis
Bear Case
$12.76
100.9%
Low target
Base Case
$14.54
+129.0%
Avg target
Bull Case
$24.66
+288.3%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$17.44
-63.6% from high
52-Week Low
$6.01
+5.7% from low
Target vs 52W High
$14.54
-16.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%